Vistagen Therapeutics Inc (VTGN)

11:19 AM

Will Vistagen Therapeutics Inc. stock gain from strong economyJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com

11:19 AM

08:18 AM

Combining machine learning predictions for Vistagen Therapeutics Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com

08:18 AM

07:57 AM

Vistagen Therapeutics Inc. stock momentum explained2025 Analyst Calls & Weekly Watchlist of Top Performers - newser.com

07:57 AM

Oct 12, 2025

What institutional flow reveals about Vistagen Therapeutics Inc.GDP Growth & Reliable Intraday Trade Plans - newser.com

Oct 12, 2025

Oct 12, 2025

Applying Elliott Wave Theory to Vistagen Therapeutics Inc.Quarterly Trade Review & Weekly Market Pulse Updates - newser.com

Oct 12, 2025

Oct 12, 2025

Tools to assess Vistagen Therapeutics Inc.’s risk profileWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com

Oct 12, 2025

Oct 11, 2025

VistaGen Therapeutics’ (VTGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World

Oct 11, 2025

Oct 10, 2025

Published on: 2025-10-10 09:33:10 - newser.com

Oct 10, 2025

Oct 10, 2025

Using Ichimoku Cloud for Vistagen Therapeutics Inc. technicalsExit Point & Intraday High Probability Setup Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Published on: 2025-10-10 04:25:39 - newser.com

Oct 10, 2025

Oct 09, 2025

VistaGen Therapeutics (NASDAQ:VTGN) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

What MACD and RSI say about Vistagen Therapeutics Inc.July 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com

Oct 09, 2025

Oct 09, 2025

Advanced analytics toolkit walkthrough for Vistagen Therapeutics Inc.July 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com

Oct 09, 2025

Oct 07, 2025

High Stakes Ahead: Vistagen's Fasedienol Trials Could Make Or Break The Story - RTTNews

Oct 07, 2025

Oct 06, 2025

Sector ETF performance correlation with Vistagen Therapeutics Inc.July 2025 Closing Moves & High Yield Stock Recommendations - newser.com

Oct 06, 2025

Oct 06, 2025

How moving averages guide Vistagen Therapeutics Inc. trading2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com

Oct 06, 2025

Oct 06, 2025

Detecting price anomalies in Vistagen Therapeutics Inc. with AIMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Has Vistagen Therapeutics Inc. found a price floorJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com

Oct 06, 2025

Oct 06, 2025

Understanding Vistagen Therapeutics Inc.’s price movement2025 Top Decliners & Verified Stock Trade Ideas - newser.com

Oct 06, 2025

Oct 05, 2025

Full technical analysis of Vistagen Therapeutics Inc. stockJuly 2025 Setups & Entry and Exit Point Strategies - newser.com

Oct 05, 2025

Oct 05, 2025

Vistagen Therapeutics Inc. stock daily chart insightsJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com

Oct 05, 2025

Oct 03, 2025

What’s the recovery path for long term holders of Vistagen Therapeutics Inc.Share Buyback & Verified Momentum Stock Watchlist - newser.com

Oct 03, 2025

Oct 03, 2025

How high can Vistagen Therapeutics Inc. stock go2025 Market Sentiment & Free Safe Capital Growth Stock Tips - newser.com

Oct 03, 2025

Oct 01, 2025

Vistagen Therapeutics Inc Stock Analysis and ForecastHigh Frequency Trading Trends & Access High Yield Alerts - earlytimes.in

Oct 01, 2025

Oct 01, 2025

Acute Social Anxiety Disorder Market on Track for Major Expansion by 2034, According to DelveInsight | GlaxoSmithKline Plc, Viatris Inc, Johnson & Johnson, Novartis AG, Pfizer Inc, AstraZeneca Plc - Barchart.com

Oct 01, 2025

Sep 30, 2025

Tools to monitor Vistagen Therapeutics Inc. recovery probabilityWatch List & Target Return Focused Picks - newser.com

Sep 30, 2025